Steve Auten, partner, Cozen O'Connor
|
|
|
ct-biz-promotions-moving-on-up-119
( September 5, 2012 ) Steve Auten has joined Cozen O'Connor as a member of the intellectual property group in Chicago. He will focus his practice on the representation of generic pharmaceutical companies in the areas of Paragraph IV design strategies, Hatch-Waxman litigation, and biosimilar market opportunities. Auten formerly was an executive and head of intellectual property for North America with Sandoz Inc, the generic pharmaceutical division of Novartis and the world's second largest generic pharmaceutical company. Auten received his Bachelor's degree from the University of Illinois at Urbana-Champaign and his law degree from the Chicago-Kent College of Law. |
Local News
Possible designs revealed for Branson 76 Strip improvements
BRANSON, Mo -- A new look for 76 Country Boulevard. It could cost up to $80 million dollars and those in charge want your feedback. The...
Deadline looms to request absentee ballots before Missouri special congressional election
JEFFERSON CITY, Mo. (AP) — Voters in southeast Missouri voters are running out of time to request absentee ballots by mail or fax...
More than 2 dozen earthquakes rumble through Arkansas in the past week
LITTLE ROCK, Ark. (AP) — More than two dozen earthquakes have rumbled through Arkansas in the past week.
Lawrence County building storm shelter location database
MOUNT VERNON, Mo.-- With this week's devastating tornado in Oklahoma, and many others over the years, the number of storm shelters in the...
Person shot at while chasing alleged thief in Christian County; three arrested
NIXA, Mo. - Three people have been taken into custody after a series of vehicle break-ins, one of which was believed to also involve...
Nurse moonlighting on Royals' fan entertainment crew revives girl, 14, who collapsed in stands
A pediatric nurse says she was in the right place at the right time to revive a 14-year-old girl who collapsed while dancing in the upper...
Twitter
Facebook
StumbleUpon
Currently there are no comments. Be the first to comment!